FeesSafety
Pluang+

Bitcoin posts negative returns for five consecutive weeks, underperforming historical averages in November 2026.

Market News
03 Nov 2026, 15:21 WIB
Tokenpost
View Source
Bearish
Bitcoin posts negative returns for five consecutive weeks, underperforming historical averages in November 2026.

Bitcoin has experienced five straight weeks of negative returns, with its weekly losses narrowing but still negative as of early November 2026. The monthly return for November stands at -0.05%, significantly below the historical average of +34.95%. Quarterly returns are also down at -7.37%, far below the usual fourth-quarter gains. Year-to-date, Bitcoin is down 12.4%, trading around $77,358 as of November 3. This trend highlights a period of underperformance compared to historical norms, signaling caution for investors.

Bitcoin's recent returns as of Nov 03, 2026 20:23 WIB provide context for cryptocurrency market activity. For readers following digital assets, here is Pluang's market snapshot: of 50 major cryptocurrencies priced on Pluang, 19 rose and 30 fell today. Notable movers include XRP at Rp23.248 with a 1-day change of +2.51% and a typical hold time of 73 days, THETA at Rp2.723 with -2.09% and 100% buy order activity, and MANA at Rp1.311 with -2.09% and 98% sell order activity. The most notable figure is XRP's 64% buy order activity.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
1 hour ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
1 hour ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
1 hour ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
2 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App